share_log

白云山(00874.HK)附属广州医药向兴证资管出售第一次新增基础资产 收到购买价款5.24亿元

Baiyunshan (00874.HK)'s subsidiary Guangzhou Medicine sells the first new underlying assets to Xingzheng Asset Management and receives a purchase price of 0.524 billion yuan.

Gelonghui Finance ·  Nov 28, 2024 17:13

Gelonghui reported on November 28 that baiyunshan ph (00874.HK) announced that on November 28, 2024, the company's non-wholly-owned subsidiary Guangzhou Medicine signed a "New Basic Asset Delivery Confirmation Letter" with Xingzheng Asset Management according to the Basic Asset Sale Agreement (Phase IV), confirming the sale of the first newly added basic asset to Xingzheng Asset Management and receiving a purchase price of 524,000,713.50 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment